---
document_datetime: 2025-11-23 11:22:06
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/prehevbri.html
document_name: prehevbri.html
version: success
processing_time: 0.1062986
conversion_datetime: 2025-12-26 21:17:00.793222
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# PreHevbri

[RSS](/en/individual-human-medicine.xml/67555)

##### Withdrawn

This medicine's authorisation has been withdrawn

hepatitis B surface antigen

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on PreHevbri](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 25 November 2024, the European Commission withdrew the marketing authorisation for PreHevbri (hepatitis B surface antigen) in the European Union (EU).

The withdrawal was at the request of the marketing authorisation holder, VBI Vaccines B.V., which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

PreHevbri was granted marketing authorisation in the EU on 25 April 2022 for active immunisation against infection caused by all known subtypes of the hepatitis B virus in adults. The marketing authorisation was initially valid for a 5-year period.

The European Public Assessment Report (EPAR) for PreHevbri is updated to indicate that the marketing authorisation is no longer valid.

PreHevbri : EPAR - Medicine Overview

Reference Number: EMA/129611/2022

English (EN) (189.86 KB - PDF)

**First published:** 18/05/2022

**Last updated:** 10/01/2025

[View](/en/documents/overview/prehevbri-epar-medicine-overview_en.pdf)

[Other languages (22)](#file-language-dropdown-422)

български (BG) (249.06 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/bg/documents/overview/prehevbri-epar-medicine-overview_bg.pdf)

español (ES) (190.15 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/es/documents/overview/prehevbri-epar-medicine-overview_es.pdf)

čeština (CS) (233.27 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/cs/documents/overview/prehevbri-epar-medicine-overview_cs.pdf)

dansk (DA) (189.99 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/da/documents/overview/prehevbri-epar-medicine-overview_da.pdf)

Deutsch (DE) (197.41 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/de/documents/overview/prehevbri-epar-medicine-overview_de.pdf)

eesti keel (ET) (178.28 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/et/documents/overview/prehevbri-epar-medicine-overview_et.pdf)

ελληνικά (EL) (260.07 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/el/documents/overview/prehevbri-epar-medicine-overview_el.pdf)

français (FR) (195.05 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/fr/documents/overview/prehevbri-epar-medicine-overview_fr.pdf)

hrvatski (HR) (219.69 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/hr/documents/overview/prehevbri-epar-medicine-overview_hr.pdf)

italiano (IT) (191.31 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/it/documents/overview/prehevbri-epar-medicine-overview_it.pdf)

latviešu valoda (LV) (258.78 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/lv/documents/overview/prehevbri-epar-medicine-overview_lv.pdf)

lietuvių kalba (LT) (230.53 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/lt/documents/overview/prehevbri-epar-medicine-overview_lt.pdf)

magyar (HU) (222.59 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/hu/documents/overview/prehevbri-epar-medicine-overview_hu.pdf)

Malti (MT) (247.29 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/mt/documents/overview/prehevbri-epar-medicine-overview_mt.pdf)

Nederlands (NL) (194.23 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/nl/documents/overview/prehevbri-epar-medicine-overview_nl.pdf)

polski (PL) (240.27 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/pl/documents/overview/prehevbri-epar-medicine-overview_pl.pdf)

português (PT) (193.14 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/pt/documents/overview/prehevbri-epar-medicine-overview_pt.pdf)

română (RO) (234.8 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/ro/documents/overview/prehevbri-epar-medicine-overview_ro.pdf)

slovenčina (SK) (234.63 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/sk/documents/overview/prehevbri-epar-medicine-overview_sk.pdf)

slovenščina (SL) (221.73 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/sl/documents/overview/prehevbri-epar-medicine-overview_sl.pdf)

Suomi (FI) (188.04 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/fi/documents/overview/prehevbri-epar-medicine-overview_fi.pdf)

svenska (SV) (186.28 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/sv/documents/overview/prehevbri-epar-medicine-overview_sv.pdf)

PreHevbri : EPAR - Risk management plan summary

English (EN) (216.19 KB - PDF)

**First published:** 18/05/2022

**Last updated:** 10/01/2025

[View](/en/documents/rmp-summary/prehevbri-epar-risk-management-plan-summary_en.pdf)

## Product information

PreHevbri : EPAR - Product Information

English (EN) (975.75 KB - PDF)

**First published:** 18/05/2022

**Last updated:** 10/01/2025

[View](/en/documents/product-information/prehevbri-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-18)

български (BG) (1.23 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/bg/documents/product-information/prehevbri-epar-product-information_bg.pdf)

español (ES) (1.01 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/es/documents/product-information/prehevbri-epar-product-information_es.pdf)

čeština (CS) (1.1 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/cs/documents/product-information/prehevbri-epar-product-information_cs.pdf)

dansk (DA) (1010.23 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/da/documents/product-information/prehevbri-epar-product-information_da.pdf)

Deutsch (DE) (1.05 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/de/documents/product-information/prehevbri-epar-product-information_de.pdf)

eesti keel (ET) (967.74 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/et/documents/product-information/prehevbri-epar-product-information_et.pdf)

ελληνικά (EL) (1.28 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/el/documents/product-information/prehevbri-epar-product-information_el.pdf)

français (FR) (1.01 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/fr/documents/product-information/prehevbri-epar-product-information_fr.pdf)

hrvatski (HR) (1.11 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/hr/documents/product-information/prehevbri-epar-product-information_hr.pdf)

íslenska (IS) (963.89 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/is/documents/product-information/prehevbri-epar-product-information_is.pdf)

italiano (IT) (1003.4 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/it/documents/product-information/prehevbri-epar-product-information_it.pdf)

latviešu valoda (LV) (1.09 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/lv/documents/product-information/prehevbri-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.13 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/lt/documents/product-information/prehevbri-epar-product-information_lt.pdf)

magyar (HU) (1.21 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/hu/documents/product-information/prehevbri-epar-product-information_hu.pdf)

Malti (MT) (1.19 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/mt/documents/product-information/prehevbri-epar-product-information_mt.pdf)

Nederlands (NL) (1.01 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/nl/documents/product-information/prehevbri-epar-product-information_nl.pdf)

norsk (NO) (1007.88 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/no/documents/product-information/prehevbri-epar-product-information_no.pdf)

polski (PL) (1.19 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/pl/documents/product-information/prehevbri-epar-product-information_pl.pdf)

português (PT) (975.02 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/pt/documents/product-information/prehevbri-epar-product-information_pt.pdf)

română (RO) (1.17 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/ro/documents/product-information/prehevbri-epar-product-information_ro.pdf)

slovenčina (SK) (1.09 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/sk/documents/product-information/prehevbri-epar-product-information_sk.pdf)

slovenščina (SL) (1.1 MB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/sl/documents/product-information/prehevbri-epar-product-information_sl.pdf)

Suomi (FI) (982.05 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/fi/documents/product-information/prehevbri-epar-product-information_fi.pdf)

svenska (SV) (986.28 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/sv/documents/product-information/prehevbri-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0008 25/11/2024

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

PreHevbri : EPAR - All authorised presentations

English (EN) (81.34 KB - PDF)

**First published:** 18/05/2022

**Last updated:** 10/01/2025

[View](/en/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-883)

български (BG) (95.33 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/bg/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_bg.pdf)

español (ES) (102.02 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/es/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_es.pdf)

čeština (CS) (124.24 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/cs/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (82.94 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/da/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (83.71 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/de/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (80.28 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/et/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (124.2 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/el/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_el.pdf)

français (FR) (81.18 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/fr/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (119.53 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/hr/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (82.29 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/is/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_is.pdf)

italiano (IT) (80.03 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/it/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (101.25 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/lv/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (103.81 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/lt/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (119.82 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/hu/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (104.6 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/mt/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (80.99 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/nl/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (81.84 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/no/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_no.pdf)

polski (PL) (106.5 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/pl/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_pl.pdf)

português (PT) (82.51 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/pt/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_pt.pdf)

română (RO) (101.49 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/ro/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (123.83 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/sk/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (118.74 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/sl/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (80.16 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/fi/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (101.76 KB - PDF)

**First published:**

18/05/2022

**Last updated:**

10/01/2025

[View](/sv/documents/all-authorised-presentations/prehevbri-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine PreHevbri Active substance hepatitis B surface antigen International non-proprietary name (INN) or common name hepatitis B surface antigen Therapeutic area (MeSH) Hepatitis B Anatomical therapeutic chemical (ATC) code J07BC01

### Pharmacotherapeutic group

Vaccines

### Therapeutic indication

PreHevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis B virus in adults.

It can be expected that hepatitis D will also be prevented by immunisation with PreHevbri as hepatitis D (caused by the delta agent) does not occur in the absence of hepatitis B infection.

The use of PreHevbri should be in accordance with official recommendations.

## Authorisation details

EMA product number EMEA/H/C/005466 Marketing authorisation holder

VBI Vaccines B.V.

Queen's Tower Office Number 714

Opinion adopted 24/02/2022 Marketing authorisation issued 25/04/2022 Revision 3

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

PreHevbri : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (227.98 KB - PDF)

**First published:** 22/03/2023

**Last updated:** 10/01/2025

[View](/en/documents/procedural-steps-after/prehevbri-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

PreHevbri : EPAR - Public Assessment Report

Adopted

Reference Number: EMA/CHMP/86102/2022

English (EN) (2.35 MB - PDF)

**First published:** 25/02/2022

**Last updated:** 10/01/2025

[View](/en/documents/assessment-report/prehevbri-epar-public-assessment-report_en.pdf)

CHMP summary of opinion for PreHevbri

Adopted

Reference Number: EMA/CHMP/87383/2022

English (EN) (195.67 KB - PDF)

**First published:** 25/02/2022

**Last updated:** 10/01/2025

[View](/en/documents/smop-initial/chmp-summary-opinion-prehevbri_en.pdf)

#### News on PreHevbri

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 February 2022](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-21-24-february-2022) 25/02/2022

**This page was last updated on** 10/01/2025

## Share this page

[Back to top](#main-content)